MedTrace Logo

Efficacy of Topical Cysteamine in Nephropathic Cyctinosis

NCT02766855 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2016-05-10

No results posted yet for this study

Summary

The aim of this study is to evaluate the efficacy of topical cysteamine eye drops in the treatment of corneal cystine crystals deposits in patients with nephropathic cystinosis.

Conditions

  • Nephropathic Cyctinosis
  • Corneal Cystine Crystals

Interventions

DRUG

Cysteamine

Patients were asked to use topical cysteamine 0.55% eye drops every 2 hours while awake to both eyes.

Sponsors & Collaborators

  • The Eye Center and The Eye Foundation for Research in Ophthalmology

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Months
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2012-12-31
Completion
2016-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02766855 on ClinicalTrials.gov